search
Back to results

LDCT in COVID-19 Pneumonia: a Prospective Moscow Study (LDCTiP)

Primary Purpose

Pneumonia, Coronavirus Infection

Status
Completed
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
Low-dose Chest CT
Sponsored by
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Pneumonia focused on measuring Low-dose CT, Community-acquired pneumonia, Computed tomography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A referral from the attending physician for a chest CT scan
  • Suspected pneumonia
  • Signed informed consent
  • Over 18 years old
  • Both male and female

Exclusion Criteria:

  • Pregnant or nursing women
  • Presence of foreign implanted objects in the body at the scan level (including cardiac pacemakers, spine metalware)
  • Patients after surgical intervention at the level of the chest organs
  • Cancer patients

Sites / Locations

  • Victor Gombolevskiy

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard Chest CT

Low-dose Chest CT

Arm Description

Outcomes

Primary Outcome Measures

Evaluate the correlation between standard CT and low-dose CT scans for the detection of community-acquired pneumonia.
A standardized scale CT1-CT4 will be used. The expected correlation percentage is 90%.

Secondary Outcome Measures

Threshold value of the infiltration zone size detected by low-dose CT scan compared to standard CT scan.
Expected threshold - 10 mm.
Number of infiltration zones of pulmonary parenchyma corresponding to viral pneumonia detected by low-dose CT scan in comparison with standard CT scan.
Expected number - more than two zones.

Full Information

First Posted
April 30, 2020
Last Updated
June 10, 2020
Sponsor
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
search

1. Study Identification

Unique Protocol Identification Number
NCT04379531
Brief Title
LDCT in COVID-19 Pneumonia: a Prospective Moscow Study
Acronym
LDCTiP
Official Title
Low-dose Computed Tomography in COVID-19 Pneumonia: a Prospective Moscow Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
April 25, 2020 (Actual)
Primary Completion Date
May 22, 2020 (Actual)
Study Completion Date
May 22, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypothesis: low-dose chest computed tomography, has the same accuracy for the diagnosis of pneumonia compared to the routine protocol. In total, 230 patients are planned to be enrolled in the study. Each patient will have 2 studies (routine chest CT and low-dose chest CT) sequentially during one visit to the computed tomography room.
Detailed Description
As of 30 April 2020, there were over 3 million confirmed cases worldwide, of which over 200,000 were fatal. In Russia at the time of writing, 106 thousand cases of COVID-19 were registered in 78 regions, with 11619 recovered and 1073 dead. Initial prospective analysis of clinical data from 41 patients in Wuhan, with laboratory confirmation of the 2019-nCoV-2 virus, showed that 2019-nCoV-2 caused severe illness, clinically similar to SARS, which sometimes led to the need for hospitalization in the intensive care unit (13 out of 41 [32 %]) and death (6 out of 41 [15%]). All patients with pneumonia in this study had changes in the chest CT scan: preliminary reports indicated that all patients had bilateral lung infiltration. Given the current prevalence of the disease and the nonspecific symptoms, we expect a significant increase in chest CT scans shortly. A low-dose chest CT scan can be performed with an effective dose of no more than 3.5 mSv, which is much lower than the dose received with a standard protocol - 8-10 mSv. The investigators hypothesize that a patient with suspected pneumonia can have a low-dose chest CT scan instead of a standard CT while maintaining the accuracy of the method in the diagnosis of inflammatory pulmonary tissue infiltration. The advantage of participating in the study for the patient is the possibility of obtaining an image without motion artifacts that may be associated with coughing, possibly affecting the patient's management tactics. The study is intended to provide answers to the following questions: The primary point of the study is to evaluate the correlation between standard CT and low-dose CT scans for the detection of community-acquired pneumonia. The expected correlation percentage is 90%. The secondary point of study No. 1 is the threshold value of the infiltration zone size detected by low-dose CT scan compared to standard CT scan. Expected threshold - 10 mm. The secondary point of study No.2 is the number of infiltration zones of pulmonary parenchyma corresponding to viral pneumonia detected by low-dose CT scan in comparison with standard CT scan. Expected number - more than two zones. In the future, it is planned to use the obtained anonymized data to enter the international registers of images of pneumonia caused by COVID-19.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pneumonia, Coronavirus Infection
Keywords
Low-dose CT, Community-acquired pneumonia, Computed tomography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
230 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Chest CT
Arm Type
Active Comparator
Arm Title
Low-dose Chest CT
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
Low-dose Chest CT
Intervention Description
Patients referred by the primary care physician with suspected pneumonia.
Primary Outcome Measure Information:
Title
Evaluate the correlation between standard CT and low-dose CT scans for the detection of community-acquired pneumonia.
Description
A standardized scale CT1-CT4 will be used. The expected correlation percentage is 90%.
Time Frame
Upon completion, up to 1 year
Secondary Outcome Measure Information:
Title
Threshold value of the infiltration zone size detected by low-dose CT scan compared to standard CT scan.
Description
Expected threshold - 10 mm.
Time Frame
Upon completion, up to 1 year
Title
Number of infiltration zones of pulmonary parenchyma corresponding to viral pneumonia detected by low-dose CT scan in comparison with standard CT scan.
Description
Expected number - more than two zones.
Time Frame
Upon completion, up to 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A referral from the attending physician for a chest CT scan Suspected pneumonia Signed informed consent Over 18 years old Both male and female Exclusion Criteria: Pregnant or nursing women Presence of foreign implanted objects in the body at the scan level (including cardiac pacemakers, spine metalware) Patients after surgical intervention at the level of the chest organs Cancer patients
Facility Information:
Facility Name
Victor Gombolevskiy
City
Moscow
ZIP/Postal Code
109029
Country
Russian Federation

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31986264
Citation
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum In: Lancet. 2020 Jan 30;:
Results Reference
background

Learn more about this trial

LDCT in COVID-19 Pneumonia: a Prospective Moscow Study

We'll reach out to this number within 24 hrs